Akari Therapeutics Plc Stock Analysis
Technical stock analysis for Tue 15'th Jan 2019
Akari Therapeutics Plc gained 0.50% in the last trading day, rising from $1.99 to $2.00 The price has risen in 7 of the last 10 days and is up by 27.39% over the past 2 weeks. Volume fell in the last day by -17 167 shares, and in total, 15 281 shares bought and sold for approximately $30 562.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Tuesday, 15th Jan 2019) of the AKTX stock was $2.00. This is 0.5% more than the trading day before Monday, 14th Jan 2019.
During day the stock fluctuated 3.51% from a day low at $1.96 to a day high of $2.03.
30 day high of the AKTX stock price was $2.05 and low was $1.56.
90 day high was $2.05 and low was $1.56.
52 week high for the Akari Therapeutics Plc - $4.06 and low - $1.56.
Akari Therapeutics Plc is the upper part of a very wide and horizontal trend and normally this would pose a good selling opportunity, but a break-up through the top trend line at $2.01 will give a strong buy signal and a trend shift may be expected. Given the current horizontal trend you can expect Akari Therapeutics Plc with 90% probability to be traded between $1.55 and $1.99 at the end of this period with 90% probability. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Akari Therapeutics Plc holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $1.90 and $1.78. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Friday January 11, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 67 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $1.82 and $1.80.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Akari Therapeutics Plc finds support just below today's level at $1.82. If this is broken, then the next support from accumulated volume will be at $1.80 and $1.76.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.07 between high and low, or 3.51%. For the last week the stock has had a daily average volatility of 6.22%.
Our recommended stoploss: $1.92 (-4.06%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 2 days ago.)
Very Low Low Medium High Very High
Akari Therapeutics Plc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.